| Predicate |
Object |
| assignee |
http://rdf.ncbi.nlm.nih.gov/pubchem/patentassignee/MD5_021ccbeb24f269f38cd842953811b956
http://rdf.ncbi.nlm.nih.gov/pubchem/patentassignee/MD5_e5fb7f6ce08a43cd7c4e2fc4c49f7b4a |
| classificationCPCAdditional |
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61K9-0019 |
| classificationCPCInventive |
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61P9-10
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61K31-198 |
| classificationIPCInventive |
http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61P9-10
http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61K31-198 |
| filingDate |
2019-12-27-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
| inventor |
http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_00f7c2a0ab80c0dd54265554f416c001
http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_18bd1b49ea58213a9e6b57a6ab10237a |
| publicationDate |
2020-07-16-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
| publicationNumber |
WO-2020144073-A1 |
| titleOfInvention |
L-triiodothyronine (t3) for use in limiting microvascular obstruction |
| abstract |
The present invention concerns the use of L-triiodothyronine (T3) in a novel treatment to limit or prevent the occurrence of Microvascular Obstruction (MVO), after a successful Primary Percutaneous Coronary Intervention (PPCI), in the course of an acute ST-segment-elevation myocardial infarction (STEMI). |
| isCitedBy |
http://rdf.ncbi.nlm.nih.gov/pubchem/patent/WO-2021214497-A1
http://rdf.ncbi.nlm.nih.gov/pubchem/patent/GR-1010156-B |
| priorityDate |
2019-01-09-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
| type |
http://data.epo.org/linked-data/def/patent/Publication |